Wilson M D, Hays R D, Clarke S D
J Nutr. 1986 Aug;116(8):1511-8. doi: 10.1093/jn/116.8.1511.
Diabetic and nondiabetic rats were used to ascertain if dietary polyunsaturated fats inhibited hepatic acetyl-CoA carboxylase and fatty acid synthetase in insulin-insufficient rats as had been previously shown for normal rats. Male rats were rendered diabetic (400-600) mg glucose/100 mL blood) with streptozotocin and were fed a high fructose fat-free diet. Safflower oil or palmitate (or tallow) was added to the basal fructose diet at a level to supply 12,24 or 36% additional digestible energy. Compared with normal rats, diabetic rats had significantly lower hepatic fatty acid biosynthesis, but the proportion of acetyl-CoA carboxylase expressing catalytic activity as determined by the avidin-inactivation technique was unaffected by diabetes. Diabetes did not lower the maximal maximal activities of carboxylase and fatty acid synthetase. Moreover, the activities of these enzymes greatly exceeded the rate of fatty acid synthesis. At all levels of fat supplementation, the high linoleate safflower oil consistently resulted in a 50% lower rate of fatty acid biosynthesis than did comparable levels of tallow or palmitate. Safflower oil was also a more effective suppressor of the activities of acetyl-CoA carboxylase and fatty acid synthetase than the saturated fats. Our data suggest that the greater inhibition of hepatic fatty acid biosynthesis by polyenoic fatty acids is an insulin-independent mechanism.
使用糖尿病大鼠和非糖尿病大鼠来确定膳食多不饱和脂肪是否像先前在正常大鼠中所显示的那样,抑制胰岛素不足大鼠肝脏中的乙酰辅酶A羧化酶和脂肪酸合成酶。雄性大鼠用链脲佐菌素诱导成糖尿病(血糖水平为400 - 600毫克/100毫升血液),并喂食高果糖无脂饮食。将红花油或棕榈酸酯(或牛脂)以提供12%、24%或36%额外可消化能量的水平添加到基础果糖饮食中。与正常大鼠相比,糖尿病大鼠肝脏脂肪酸生物合成显著降低,但通过抗生物素蛋白失活技术测定的表达催化活性的乙酰辅酶A羧化酶比例不受糖尿病影响。糖尿病并未降低羧化酶和脂肪酸合成酶的最大活性。此外,这些酶的活性大大超过脂肪酸合成速率。在所有脂肪补充水平下,高亚油酸红花油导致的脂肪酸生物合成速率始终比同等水平的牛脂或棕榈酸酯低50%。红花油也是比饱和脂肪更有效的乙酰辅酶A羧化酶和脂肪酸合成酶活性抑制剂。我们的数据表明,多烯脂肪酸对肝脏脂肪酸生物合成的更大抑制是一种不依赖胰岛素的机制。